AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants
by Adam Feuerstein and Matthew Herper
Jun 25, 2019
1 minute
AbbVie said Tuesday it will acquire Allergan for $63 billion — the latest megamerger between two pharma giants seeking new ways to grow.
The deal, combining two firms built by past acquisitions, represents. The big prize for AbbVie is Allergan’s franchise of aesthetics drugs, , which has annual sales of $3.6 billion.
You’re reading a preview, subscribe to read more.
Start your free 30 days